William Larkins
Corporate Officer/Principal chez HIKMA PHARMACEUTICALS PLC
Profil
William C.
Larkins is currently the President-Injectables Business at Hikma Pharmaceuticals Plc.
Prior to his current position, he served as the Chief Executive Officer & Director at CUSTOpharm, Inc. Dr. Larkins holds a doctorate degree from The Ohio State University and an undergraduate degree from Purdue University.
Postes actifs de William Larkins
Sociétés | Poste | Début |
---|---|---|
HIKMA PHARMACEUTICALS PLC | Corporate Officer/Principal | 01/01/2022 |
Anciens postes connus de William Larkins
Sociétés | Poste | Fin |
---|---|---|
CUSTOpharm, Inc.
CUSTOpharm, Inc. Pharmaceuticals: MajorHealth Technology CUSTOpharm, Inc. provides personalized chemistry and regulatory support services. It provides personalized cost-effective chemistry and manufacturing controls (CMC) and regulatory support to companies with limited resources and those seeking to expand into new areas. The firm offers product development services that focus on non-clinical, clinical, marketing, and other aspects of drug development and distribution; sourcing of product manufacturing with specialization in injectable dosage forms, including suspensions, lyophilized, and cytotoxic compounds, technology transfer, regulatory support, such as electronic submissions, electronic hybrids, paper applications/CTD/traditional format, structured product labeling. The company was founded by David McCleary in 2005 and is headquartered in San Diego, CA. | Chief Executive Officer | 01/09/2022 |
Formation de William Larkins
The Ohio State University | Doctorate Degree |
Purdue University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
HIKMA PHARMACEUTICALS PLC | Health Technology |
Entreprise privées | 1 |
---|---|
CUSTOpharm, Inc.
CUSTOpharm, Inc. Pharmaceuticals: MajorHealth Technology CUSTOpharm, Inc. provides personalized chemistry and regulatory support services. It provides personalized cost-effective chemistry and manufacturing controls (CMC) and regulatory support to companies with limited resources and those seeking to expand into new areas. The firm offers product development services that focus on non-clinical, clinical, marketing, and other aspects of drug development and distribution; sourcing of product manufacturing with specialization in injectable dosage forms, including suspensions, lyophilized, and cytotoxic compounds, technology transfer, regulatory support, such as electronic submissions, electronic hybrids, paper applications/CTD/traditional format, structured product labeling. The company was founded by David McCleary in 2005 and is headquartered in San Diego, CA. | Health Technology |